Position in LLY
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$203,695,943
-$42,534,761 QoQ
Shares Held
221,464
-3.3% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
1.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MetLife Investment Management, LLC holds $714,031,909 across 12 Drug Manufacturers - General names. LLY ranks #1 (28.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
221,464 | $203,695,943 | |
| 2 | JNJ |
Johnson & Johnson
|
563,045 | $137,630,719 | |
| 3 | ABBV |
AbbVie Inc.
|
493,002 | $107,223,004 | |
| 4 | MRK |
Merck & Co., Inc.
|
580,004 | $69,768,681 | |
| 5 | AMGN |
Amgen Inc
|
143,722 | $50,568,585 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
305,106 | $42,522,623 | |
| 7 | PFE |
Pfizer Inc
|
1,328,456 | $37,303,044 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
493,565 | $29,934,717 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $203,695,943 | 221,464 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $246,230,704 | 229,120 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $179,533,900 | 235,300 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $184,863,980 | 237,148 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $198,010,270 | 239,748 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $188,429,760 | 244,080 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $214,220,292 | 241,800 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $229,377,117 | 253,349 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $173,231,465 | 222,674 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $133,731,174 | 229,416 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $125,410,186 | 233,482 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $110,872,968 | 236,413 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $79,688,207 | 232,043 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $85,756,920 | 234,411 | Shares | Defined | 2023-03-23 | |
| 2022-09-30 | $77,260,278 | 238,937 | Shares | Defined | 2023-03-23 | |
| 2022-06-30 | $78,369,957 | 241,711 | Shares | Defined | 2023-03-23 | |
| 2022-03-31 | $70,762,599 | 247,102 | Shares | Defined | 2023-03-23 | |
| 2021-12-31 | $48,455,064 | 175,422 | Shares | Defined | 2023-03-23 | |
| 2021-09-30 | $42,252,113 | 182,870 | Shares | Defined | 2023-03-23 | |
| 2021-06-30 | $42,357,227 | 184,547 | Shares | Defined | 2023-03-23 | |
| 2021-03-31 | $35,414,533 | 189,565 | Shares | Defined | 2023-03-23 | |
| 2020-12-31 | $32,555,391 | 192,818 | Shares | Defined | 2023-03-23 | |
| 2020-09-30 | $29,793,613 | 201,281 | Shares | Defined | 2023-03-23 | |
| 2020-06-30 | $36,163,107 | 220,265 | Shares | Defined | 2023-03-23 | |
| 2020-03-31 | $30,211,551 | 217,788 | Shares | Defined | 2023-03-23 | |
| No filing history on record for this holder in this stock. | ||||||